Causes
By Mayo Clinic staffType 2 diabetes develops when the body becomes resistant to insulin or when the pancreas stops producing enough insulin. Exactly why this happens is unknown, although excess weight and inactivity seem to be contributing factors.
Insulin is a hormone that comes from the pancreas, a gland situated just behind and below the stomach. When you eat, the pancreas secretes insulin into the bloodstream. As insulin circulates, it acts like a key by unlocking microscopic doors that allow sugar to enter your cells. Insulin lowers the amount of sugar in your bloodstream. As your blood sugar level drops, so does the secretion of insulin from your pancreas.
Glucose — a sugar — is a main source of energy for the cells that make up muscles and other tissues. Glucose comes from two major sources: the food you eat and your liver. After intestinal digestion and absorption, sugar is absorbed into the bloodstream. Normally, sugar then enters cells with the help of insulin.
The liver acts as a glucose storage and manufacturing center. When your insulin levels are low — when you haven't eaten in a while, for example — the liver metabolizes stored glycogen into glucose to keep your glucose level within a normal range.
In type 2 diabetes, this process works improperly. Instead of moving into your cells, sugar builds up in your bloodstream. This occurs when your pancreas doesn't make enough insulin or your cells become resistant to the action of insulin.
In type 1 diabetes, which is much less common, the pancreas produces little or no insulin.
- Diabetes mellitus (DM). The Merck Manuals: The Merck Manual for Healthcare Professionals. http://www.merck.com/mmpe/sec12/ch158/ch158b.html#sec12-ch158-ch158b-1105. Accessed Feb. 22, 2011.
- Standards of medical care in diabetes — 2011. Diabetes Care. 2011:34:S11.
- McCulloch DK, et al. Risk factors for type 2 diabetes mellitus. http://www.uptodate.com/home/index.html. Accessed Feb. 18, 2011.
- Your guide to diabetes: Type 1 and type 2. National Institute of Diabetes and Digestive and Kidney Diseases. http://diabetes.niddk.nih.gov/dm/pubs/type1and2/index.htm. Accessed Feb. 22, 2011.
- McCulloch DK. Initial management of blood glucose in type 2 diabetes mellitus. http://www.uptodate.com/home/index.html. Accessed Feb. 18, 2011.
- McCulloch DK, et al. Prediction and prevention of type 2 diabetes mellitus. http://www.uptodate.com/home/index.html. Accessed Feb. 18, 2011.
- Screening for type 2 diabetes mellitus in adults. U.S. Preventive Services Task Force. http://www.uspreventiveservicestaskforce.org/uspstf08/type2/type2rs.htm. Accessed Feb. 27, 2011.
- Diabetes statistics. American Diabetes Association. http://www.diabetes.org/diabetes-basics/diabetes-statistics. Accessed Feb. 27, 2011.
- What people with diabetes need to know about osteoporosis. National Institute of Arthritis and Musculoskeletal and Skin Diseases. http://www.niams.nih.gov/Health_Info/Bone/Osteoporosis/Conditions_Behaviors/diabetes.asp. Accessed Feb. 22, 2011.
- Helzner EP, et al. Contribution of vascular risk factors to the progression in Alzheimer disease. Archives of Neurology. 2009;66:343.
- Bainbridge KE. Diabetes and hearing impairment in the United States: Audiometric evidence from the National Health and Nutrition Examination Survey, 1999 to 2004. Annals of Internal Medicine. 2008;149:1.
- Baker WL, et al. Effect of cinnamon on glucose control and lipid parameters. Diabetes Care. 2008;31:41.
- Balk EM, et al. Effect of chromium supplementation on glucose metabolism and lipids. 2007;30:2154.
- Huxley R, et al. Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus. Archives of Internal Medicine. 2009;169:2053.
- Hyperosmolar hyperglycemic nonketotic syndrome (HHNS). American Diabetes Association. http://www.diabetes.org/living-with-diabetes/complications/hyperosmolar-hyperglycemic.html. Accessed Feb. 27, 2011.
- Diabetic ketoacidosis. National Center for Biotechnology Information. http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001363. Accessed Feb. 24, 2011.
- Frye RL, et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. New England Journal of Medicine. 2009;360:2503.
- Centers for Disease Control and Prevention, et al. Use of hepatitis B vaccine for adults with diabetes mellitus: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and Reports. 2011:60;1709.

Find Mayo Clinic on